Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
457.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 12.20 (2.665%)
Market Cap: £689.02m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Directorate Change

31 Dec 2020 07:00

RNS Number : 1972K
Close Brothers Group PLC
31 December 2020
 

Directorate change

The board of directors of Close Brothers Group plc ("Close Brothers" or the "Company") is pleased to announce the appointment of Mark Pain as an independent non-executive director with effect from 1 January 2021.

On joining the board, Mark will become a member of the board's Nomination & Governance and Risk Committees, and will also become the Company's Senior Independent Director. At the same time, and consistent with the Company's other independent non-executive directors, he will also become a director of the Company's Banking subsidiary, Close Brothers Limited.

Mark Pain has more than 30 years' executive and non-executive experience in financial services, including in retail banking and insurance. He has strong finance, risk management and commercial credentials, having held board positions at Barratt Developments plc, where he was Group Finance Director, and Abbey National Group, where he was Group Finance Director, Chief Executive Officer of Abbey National Treasury Services, and Director, Customer Sales.

Mark has broad experience as a non-executive director in both public and private companies. He has previously been a non-executive director of Yorkshire Building Society (where he served as Senior Independent Director), Ladbrokes Coral Group plc, Punch Taverns plc, Spirit Pub Company plc, Johnston Press plc, and Aviva Insurance Limited, among others.

Mark is currently a non-executive director of AXA UK plc, where he serves on the Audit, Investment, Remuneration, Nomination, and Risk Committees. He is Chairman of London Square Limited and Empiric Student Property plc.

Mark takes over as the Company's Senior Independent Director from Oliver Corbett, who has held the position on an interim basis since the retirement of Geoffrey Howe from the board on 19 November 2020. Oliver continues to chair the board's Audit Committee.

Mike Biggs, Chairman of Close Brothers, commented: "I am delighted to be welcoming Mark to the Close Brothers board. He brings very extensive experience of the financial services sector, and as a listed company non-executive director including as a senior independent director. Mark's appointment further strengthens the range of skills and expertise represented on the board, and I look forward to working with him in the years ahead. On behalf of the board, I would like to thank Oliver Corbett for carrying out the role of Senior Independent Director since November."

Mark Pain said: "I am very pleased to be joining the board of Close Brothers. Close Brothers has a long and successful track record under-pinned by its distinctive purpose and culture. I look forward to working with the board and senior management to play a part in the continuing development of the group."

No other information is required to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules in relation to Mark's appointment as a director of Close Brothers.

Enquiries

Alex Dunn

Company Secretary and Head of Legal(Corporate & Bank Retail)Close Brothers Group plc

 

 

020 3857 6057

Sophie Gillingham

Director of Investor Relations

Close Brothers Group plc

 

020 3857 6574

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ over 3,500 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABLBDDSUXDGGG
Date   Source Headline
1st Jun 20264:15 pmRNSTotal Voting Rights
21st May 20265:15 pmRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSTrading Statement
13th May 20261:00 pmRNSRedemption of Subordinated Notes due 2031
6th May 20264:00 pmRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSTotal Voting Rights
29th Apr 202612:15 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20265:45 pmRNSHolding(s) in Company
14th Apr 20265:00 pmRNSDirector/PDMR Shareholding
9th Apr 20265:15 pmRNSDirector/PDMR Shareholding
8th Apr 20264:46 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSUpdate in relation to motor finance commissions
1st Apr 20264:15 pmRNSTotal Voting Rights
30th Mar 20265:08 pmRNSStatement in relation to motor finance commissions
17th Mar 20264:30 pmRNSTransaction in Own Shares
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
16th Mar 20265:40 pmRNSStatement regarding report from Viceroy Research
6th Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:45 pmRNSTotal Voting Rights
23rd Feb 20264:45 pmRNSTransaction in Own Shares
16th Feb 20264:30 pmRNSTransaction in Own Shares
9th Feb 20265:45 pmRNSDirector/PDMR Shareholding
9th Feb 20265:30 pmRNSTransaction in Own Shares
3rd Feb 20269:40 amRNSResult of Tender Offer
2nd Feb 20265:25 pmRNSTransaction in Own Shares
2nd Feb 20265:10 pmRNSTotal Voting Rights
30th Jan 20263:00 pmRNSPublication of Admission Particulars
26th Jan 20265:00 pmRNSTransaction in Own Shares
26th Jan 20269:20 amRNSTender Offer
19th Jan 20265:30 pmRNSTransaction in Own Shares
12th Jan 20265:45 pmRNSDirector/PDMR Shareholding
12th Jan 20263:45 pmRNSTransaction in Own Shares
7th Jan 20265:45 pmRNSTransaction in Own Shares
6th Jan 20265:15 pmRNSDirector/PDMR Shareholding
5th Jan 20262:45 pmRNSTotal Voting Rights
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSTransaction in Own Shares
22nd Dec 20253:30 pmRNSTransaction in Own Shares
15th Dec 20254:00 pmRNSHolding(s) in Company
15th Dec 202512:02 pmRNSTransaction in Own Shares
8th Dec 20255:15 pmRNSDirector/PDMR Shareholding
2nd Dec 20254:30 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSClose Brothers completes Winterflood sale to Marex
28th Nov 20254:45 pmRNSDirector/PDMR Shareholding
24th Nov 20255:00 pmRNSTransaction in Own Shares
20th Nov 20252:34 pmRNSResult of AGM
20th Nov 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.